Skip to main content
Tuesday, November 18, 2025 - 12:01pm
Galena Biopharma

"Pharma Bro' and notorious bear Martin Shkreli is shorting Olema Pharmaceuticals stock.

Read more
Tuesday, November 18, 2025 - 11:50am
Karp Takes Aim At Critics

Palantir Technologies Inc. (NASDAQ:PLTR) shares are trading lower Tuesday, extending losses from recent sessions.

Read more
News, Movers
Tuesday, November 18, 2025 - 11:28am
Los,Angeles,,Ca,,Usa,-,May,11,,2022:,Exterior,View

AECOM (NYSE: ACM) reported 2% Y/Y revenue growth to $4.18B in Q4, short of $4.31B consensus. Adjusted EBITDA up 13%.

Read more
Tuesday, November 18, 2025 - 11:27am
In this photo illustration, Freeport-McMoRan Inc., often called Freeport, is an American mining company logo seen displayed on a tablet.

Freeport-McMoRan shares are trading higher Tuesday after the company announced plans to restore large-scale production.

Read more
News, Movers
Tuesday, November 18, 2025 - 11:13am
In this photo illustration, the HIVE Blockchain logo seen displayed on a smartphone screen.

HIVE reported upbeat fiscal Q2 results, but stock fell. Analysts maintain Buy ratings and expect strong growth in AI business with minimal capex.

Read more
Tuesday, November 18, 2025 - 11:07am
Klarna website on a phone

Klarna Group PLC (NASDAQ: KLAR) reported third-quarter earnings before the market open on Tuesday. Here's a rundown of the report.

Read more
Earnings, News, Movers
Tuesday, November 18, 2025 - 11:04am
Lucid Group
News, Movers
Tuesday, November 18, 2025 - 11:01am
Target logo on building

Target Corporation (NYSE:TGT) shares are trading higher Tuesday ahead of third-quarter earnings later this week.

Read more
News, Movers
Tuesday, November 18, 2025 - 10:54am
Global-E Online

Global-E Online will report Q3 results on Wednesday, with an expected upside despite macro challenges, says Needham analyst Scott Berg.

Read more
Tuesday, November 18, 2025 - 10:49am
Wegovy

Vanda Pharmaceuticals' tradipitant successfully reduced Wegovy-induced vomiting by 50% in a clinical trial. Phase 3 anticipated in H1 2026.

Read more